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Abstract
The bacterial factors responsible for the variation in invasive potential between different clones and serotypes of
Streptococcus pneumoniae are largely unknown. Therefore, the isolation of rare serotype 1 carriage strains in Indigenous
Australian communities provided a unique opportunity to compare the genomes of non-invasive and invasive isolates of
the same serotype in order to identify such factors. The human virulence status of non-invasive, intermediately virulent and
highly virulent serotype 1 isolates was reflected in mice and showed that whilst both human non-invasive and highly
virulent isolates were able to colonize the murine nasopharynx equally, only the human highly virulent isolates were able to
invade and survive in the murine lungs and blood. Genomic sequencing comparisons between these isolates identified 8
regions .1 kb in size that were specific to only the highly virulent isolates, and included a version of the pneumococcal
pathogenicity island 1 variable region (PPI-1v), phage-associated adherence factors, transporters and metabolic enzymes. In
particular, a phage-associated endolysin, a putative iron/lead permease and an operon within PPI-1v exhibited niche-
specific changes in expression that suggest important roles for these genes in the lungs and blood. Moreover, in vivo
competition between pneumococci carrying PPI-1v derivatives representing the two identified versions of the region
showed that the version of PPI-1v in the highly virulent isolates was more competitive than the version from the less
virulent isolates in the nasopharyngeal tissue, blood and lungs. This study is the first to perform genomic comparisons
between serotype 1 isolates with distinct virulence profiles that correlate between mice and humans, and has highlighted
the important role that hypervariable genomic loci, such as PPI-1v, play in pneumococcal disease. The findings of this study
have important implications for understanding the processes that drive progression from colonization to invasive disease
and will help direct the development of novel therapeutic strategies.
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Introduction
Streptococcus pneumoniae (the pneumococcus) is a leading cause of
bacterial pneumonia, invasive disease (bacteremia and meningitis
[IPD]) and otitis media, and is responsible for .1 million deaths in
children ,5 years of age annually [1]. However, the ability of
different serotypes and clones to cause IPD varies and has led to
the grouping of serotypes and clonal clusters according to invasive
potential [2–5]. In particular, serotype 1 pneumococci have
repeatedly been reported to have a high invasive potential due to
the rarity of asymptomatic carriage [2,5]. Furthermore, serotype 1
isolates frequently cause disease in patients without an underlying
illness and as such behave as a primary pathogen [6]. In spite of
this, whilst serotype 1 isolates have a high invasive potential,
commonly studied serotype 1 clones tend to cause less severe
disease in both humans and mice when compared to certain other
serotypes and clones that behave as opportunistic pathogens [4,6].
However, a number of clones from the ST217 clonal cluster
(CC217) have been responsible for African epidemics of IPD with
unusually high mortality rates, and are considered to be
hypervirulent. In contrast to these hypervirulent clones, relatively
high rates of serotype 1 asymptomatic carriage have been reported
in a number of communities following vaccination with the 7-
valent conjugate vaccine [7,8]. In particular, serotype 1 carriage
by ST304 and ST227 clones was detected in a number of remote
Indigenous communities in Australia, without an associated
increase in serotype 1 IPD in the same communities [8].
Therefore, it is clear that considerable variation in virulence exists
between strains of the same serotype, which in turn highlights the
contribution that serotype-independent factors play in virulence.
Of particular interest is the existence of many ‘accessory regions’
(AR) within the pneumococcal genome that may contribute to
such differences in virulence [9–14]. However, whilst a number of
potential virulence determinants such as the pilus encoded within
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the rlrA islet and the pneumococcal serine rich repeat protein
(PsrP) have received particular attention, little consistency between
the presence of specific virulence determinants and invasive
potential has been found in large-scale comparisons [10,14–21].
Nevertheless, it is possible that such large-scale comparisons fail to
take into account the significant differences in virulence that may
exist within groups of isolates with apparently equivalent invasive
potential, such as hypervirulent and moderately virulent serotype 1
clones [14]. In addition, comparisons across serotypes risk
underestimating the impact of the serotype itself on virulence,
due to serotype-specific structural differences in the capsule that
can affect complement deposition and resistance against phago-
cytosis [22–25]. Therefore, by comparing the genomes of non-
invasive and invasive serotype 1 isolates, it is possible to identify
serotype-independent factors that alter the outcome of infection.
Initially, the human virulence status of non-invasive and invasive
serotype 1 isolates was confirmed in mouse models of infection,
enabling these isolates to be grouped as non-invasive, intermedi-
ately virulent and highly virulent. Using these virulence profiles as
a basis, preliminary comparisons between the three virulence
phenotypes were performed using comparative genomic hybrid-
ization (CGH), and next generation genome sequencing technol-
ogy. These comparisons identified a number of previously
described ARs as well as new ARs that were present only in the
highly virulent isolates. Of particular significance was that the
highly virulent isolates harbored a version of the pneumococcal
pathogenicity island 1 (PPI-1) that conferred greater competitive-
ness in vivo than the versions in less virulent isolates.
Results and Discussion
The virulence of serotype 1 isolates in mouse models of
infection mimics human disease
An intraperitoneal (i.p.) mouse challenge model identified three
distinct virulence phenotypes by comparing the virulence of a
collection of serotype 1 isolates (Fig. 1A). Menzies1-1 (strain 1) and
Menzies1-2 (strain 2) were avirulent in mice, which mimicked their
non-invasiveness in humans. Menzies1-1861 (strain 1861) and
WCH4496 (strain 4496) were highly virulent in mice, as mice
infected with these strains had significantly reduced survival times
than those challenged with the other two invasive isolates.
Menzies1-3415 (strain 3415) and Menzies1-5482 (strain 5482)
were considered to be intermediately virulent, as they were not
carried asymptomatically in humans, but they were less virulent
than strains 1861 and 4496 in mice. The virulence of strains 3415
and 5482 appears to be similar to the relatively low virulence of
most serotype 1 isolates in mice that has been reported previously
[4,6]. An intranasal (i.n.) mouse challenge model also confirmed
the differences in virulence between the non-invasive strain 1 and
the highly virulent strains 1861 and 4496 (Fig. 1B). A feature of the
highly virulent isolates was their ability to either cause rapidly
fulminant infection within 60 h of challenge, or not cause
detectable disease at all. Interestingly, daily analysis of bacteremia
in all mice revealed that in surviving mice pneumococci did not
reach a detectable level within the blood at any time (data not
shown). Further characterization of the pathogenicity of strains 1,
1861 and 4496 was performed by comparing the recovery of
pneumococci in the nasopharynx, blood and lungs at both 48 h
and 96 h post-challenge using an i.n. mouse challenge model
(Fig. 2). At 48 h a small but significant difference was observed
between the number of pneumococci in the nasopharynx between
strains 1861 and 4496 (Fig. 2A[i]). However, there was no
significant difference in the number of bacteria recovered from the
nasopharynx of strain 1-infected mice when compared to either of
the highly virulent strains at either timepoint (Fig. 2A[ii]). No
pneumococci were recovered from either the blood or lungs of
strain 1-infected mice, which was in stark contrast to the numbers
recovered from both strain 1861- and 4496-infected mice at 48 h
(Fig. 2B[i] and C[i]). Whilst there was a small, but significant
difference in the level of bacteremia between strains 1861 and
4496, this difference was minimal compared to strain 1. As shown
in Figure 2, mice challenged with either of the highly virulent
strains either develop fulminant infection within 60 h or survive
the challenge completely. Therefore, the strain 1861- and 4496-
infected mice analyzed at 96 h represent surviving mice, and
unsurprisingly lack detectable numbers of pneumococci in either
Figure 1. Confirmation of virulence in mice of non-invasive and
invasive serotype 1 isolates. Survival times were recorded following
i.p. (A) or i.n. (B) challenge with approximately 104 CFU and 107 CFU of
the relevant strain, respectively. Experiments were undertaken for 216 h
and 252 h following i.p. and i.n. challenge, respectively. Horizontal
broken lines indicate the median survival time. Statistical significance
was calculated using the two-tailed Mann-Whitney U test. (*, +, P,0.05).
‘*’ indicates comparison with non-invasive isolates; ‘+’ indicates
comparison with intermediately virulent isolates.
doi:10.1371/journal.pone.0019650.g001
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the blood or lungs (Fig. 2B[ii] and 2C[ii]). The fact that a
proportion of mice completely survive i.n. challenge is most likely a
consequence of mouse-mouse variation in the actual number of
pneumococci aspirated into the lungs immediately following i.n.
challenge. However, most importantly the key difference between
the non-invasive and highly virulent phenotypes is the ability of the
latter to invade and survive in the blood and lungs. We used
MLST to examine whether the strains with differing virulence
profiles had any clonal relationship. Strains 1 and 2 (ST304), and
strains 3415 and 5482 (ST227), belong to the lineage A of serotype
1 clones [26], whereas the highly invasive strains 1861 (ST3079)
and 4496 (ST3018) belong to lineages B and C, respectively. In
particular, strain 1861 was found to be a single-locus variant of
ST217 and a double-locus variant of ST618 and ST303, which
were the dominant clones responsible for epidemics of severe
serotype 1 IPD in parts of Africa [27–29]. Therefore, the
heightened virulence of strain 1861 in mice is consistent with the
severity of disease in humans caused by clonally-related strains. A
summary of the virulence and MLST data of the serotype 1
isolates used in this study is shown in Table 1.
Genetic differences between the non-invasive,
intermediately virulent and highly virulent strains were
identified by genomic sequencing
Genome comparisons were performed between the serotype 1
isolates in order to identify ARs present in the highly virulent
strains that might be responsible for their heightened virulence.
Genomic comparisons were initially performed by sequencing the
genomes of strains 1 and 1861. The presence of regions .1 kb in
size that were present only in strain 1861 was subsequently tested
in all six serotype 1 isolates by PCR to identify those regions
associated with heightened virulence. The primers used in these
PCRs are listed in Table S1. In this study, we focused attention on
regions .1 kb, as these were likely to encode an intact gene
product, and probably represent horizontally acquired genetic
material. Of course, the importance of smaller regions (,1 kb),
which might encode bacteriocins, signaling peptides, or regulatory
RNAs, as well as single nucleotide polymorphisms (SNPs) in
coding and non-coding regions should not be discounted.
Nevertheless, the expansive pool of ARs available to the
pneumococcal genome warranted paying particular attention to
these larger regions. The presence of key regions that have
previously been associated with virulence in other studies but not
associated with virulence in this study was confirmed by
comparative genomic hybridization (CGH). The P1031 (ST303;
lineage B) and INV104B (ST227; lineage A) genome sequences
were most closely aligned with strains 1861 and 1, respectively.
Regions associated with heightened virulence
Eight regions .1 kb in size were identified in both of the highly
virulent isolates but absent in all four less invasive isolates (Table 2).
A detailed list of each gene present in each AR is included in Table
S2. Of these regions, those designated 1, 2, 5, 6 and 7 have not
previously been identified as ARs [14].
Region 1 consists of a temperate bacteriophage genome with
greatest homology to SPP_0028–0084 in P1031 and to a lesser
extent the Streptococcus oralis PH10 phage [30]. The prophage is
inserted into a position between genes homologous to SP_0019
(adenylosuccinate synthetase) and 0020 (cytidine/deoxycytidylate
deaminase) in TIGR4 and SPINV104_00170 and 00180 in
INV104. In addition, examination of the sequence of the integrase
gene (SPP_0028) suggests that the phage in strains 1861 and 4496
belongs to the group 1 pneumophage [31,32]. This prophage
encodes genes homologous to platelet-binding protein B (PblB)
and an endolysin, both of which are required for the virulence of
Streptococcus mitis in an animal model of infective endocarditis [33].
PblB and the endolysin have been shown to be required by S. mitis
for adherence to human platelets [34–36]. However, a similar role
for the products of these genes in S. pneumoniae has yet to be
demonstrated. Interestingly, the endolysin gene shares 80%
nucleotide sequence identity with the major autolysin (N-
acetylmuramoyl-L-alinine amidase; lytA), which is an important
pneumococcal virulence factor [37–40]. Of the publicly available
genome sequences, only strain P1031 contains sequences homol-
ogous to the full length of region 1 represented by the prophage.
However, Hungary19A-6, JJA, 70585, OXC141, SPN994039,
SPN034183, SPN994038, and SPN034156 possess pblB- and
endolysin-(in addition to lytA-) like genes at a similar genomic
location.
Region 2 encodes a putative MerR family transcriptional
regulator and MutT/Nudix family protein homologous to
SPP_0750 and 0751, respectively. In addition, the gene encoding
a putative sodium-dependent permease was truncated in the non-
invasive and intermediately virulent strains due to the absence of
region 2. However, it is not clear whether the gene is functional in
the highly virulent strains due to a frameshift mutation
approximately 220 bp downstream of the start codon. Region 2
is inserted between genes homologous to SPINV104_06130 and
06140 in INV104. The genes in region 2 are also present in
numerous other genomes including TIGR4 (SP_0737–0740), D39,
ATCC 700669, JJA, 70585, Taiwan19F-14, G54, CGSP14,
INV200, SPN034156, OXC141, SPN994039, SPN034183,
SPN994038 and TCH8431/19A. A MerR family transcriptional
Figure 2. Number of S. pneumoniae CFU recovered from the nasopharynx, lungs and blood of infected mice. The number of CFU
recovered from the nasopharynx (A), lungs (B) and blood (C) of CD1 mice was determined at 48 h (i) and 96 h (ii) post-challenge. The horizontal
broken lines in each strain group indicate the geometric mean number of CFU that were recovered. Statistical differences were analyzed by two-
tailed unpaired t-test on log-transformed values (*, P,0.05; **, P,0.01; ***, +++ P,0.001). ‘*’ indicates comparison with 4496 and ‘+’ indicates
comparison with 1861. The single horizontal spotted line indicates the limit of detection (LD) which equates to 102 CFU/nasopharynx, 26102 CFU/
lung and 102 CFU/ml blood.
doi:10.1371/journal.pone.0019650.g002
Table 1. Serotype 1 isolates used in this study.
Isolate ST (Lineage*) Virulence status+
Menzies1-1 304 (A) Non-invasive
Menzies1-2 304 (A) Non-invasive
Menzies1-3415 227 (A) Intermediately virulent
Menzies1-5482 227 (A) Intermediately virulent
Menzies1-1861 3079 (B) Highly virulent
WCH4496‘ 3018 (C) Highly virulent
*Lineage is as described in Brueggemann et al. [26].
‘Non-Indigenous isolate. Other isolates were all of Indigenous origin.
+Non-invasive isolates were both non-invasive in humans and mice:
intermediately virulent strains were virulent in humans, but significantly less
virulent in mice than strains 1861 and 4496. Highly virulent strains were
significantly more virulent than the other four strains.
doi:10.1371/journal.pone.0019650.t001
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regulator in S. pneumoniae (SP_1856) has been shown to be involved
in nitric oxide stress and is required for full systemic virulence [41].
Regions 3 and 4 consist of the previously described AR 22 [14],
also known as the PPI-1 variable region (PPI-1v). PPI-1v appears
to be a hotspot for recombination and in some strains contains the
PezAT toxin-antitoxin (TA) system, which has been implicated in
virulence [42–44]. An alignment between PPI-1v from the lineage
A isolates and the highly virulent isolates shows the relative
position of regions 3 and 4 and is compared with the region in
ATCC 700669 and G54 (Fig. 3). In addition, this alignment shows
that PPI-1v consists of two variable components: the pezAT region
(region 3) and an accessory region (region 4) (Fig. 4). In this study,
pezAT was present only in the highly virulent isolates and not in
either the intermediately virulent or non-invasive isolates (Table 2).
In addition to pezAT itself, the non-invasive and intermediately
virulent isolates lack most of the neopullulanase gene (SP_1046;
nplT). However, since nplT is fragmented in strains 1861 and 4496,
it is unlikely that a functional protein is produced by these strains.
The pezAT region is present in numerous other strains including
JJA, ATCC 700669, CGSP14, OXC141, SPN034156,
SPN034183, SPN994038, D39, INV200 and 70585 and as such
is not unique to 1861 and 4496. Between regions 3 and 4 is a 3-kb
region of a Tn5252-like sequence that is approximately 95%
identical in all six strains (Fig. 3). Within this 3-kb region is a 1.5-
kb deletion in the non-invasive and intermediately virulent isolates,
which has led to the loss of a putative Rgg/GadR/MutR family
transcriptional regulator. However, this gene is unlikely to be
functional in the highly virulent strains, due to a previously
characterized frameshift mutation [45]. This mutation led to the
loss of ropB expression in S. pyogenes, which was responsible for loss
of SpeB expression and reduced virulence in murine systemic
models of infection. As can be seen in Fig. 3 the PPI-1v accessory
region, which consists of region 4, is a section of divergent
sequence. In the highly virulent strains, the accessory region is 8-
kb in size and includes a putative operon encoding hypothetical
proteins and metabolic enzymes such as 3-hydroxyisobutyrate
dehydrogenase (3HIBDH), prephenate dehydratase (PDT) and
UDP-glucose 4-epimerase (GalE). Downstream of this operon is a
putative biotin carboxylase and a fragmented transporter of the
major facilitator superfamily. Of the publicly available genomes,
G54, 11-BS70 and MLV-016 also contain this region 4 sequence.
However, unlike strains 1861 and 4496, the genomes of G54, 11-
BS70 and MLV-016 lack pezAT. The PPI-1v accessory region in
the non-invasive and intermediately virulent isolates contains a
fragmented lantibiotic modification and export gene, and a
putative lantibiotic immunity system ABC transporter (Table 3).
However, the region lacks the structural gene for mersacidin
lantibiotic and lantibiotic modifying enzymes. This version of
PPI-1v has previously been described in the pezAT-positive
strain ATCC 700669 [43] and is homologous to ORFs
SPINV104_09130–09190 in the pezAT-negative strain INV104.
This version of the region is also present in the pezAT-positive
strains JJA, SPN033038 and SPN032672.
Region 5 includes the putative zinc metalloproteinase D (ZmpD)
and Tn5253, which are homologous to SPP_1141–1198 in P1031.
However, this region is not present in TIGR4 or INV104 and is
inserted between homologues of SP_1154 and 1155, and
SPINV104_09960 and 09970, respectively. Other pneumococcal
Zmps include the IgA protease and ZmpC, which function to cleave
host IgA and activate human matrix metalloprotease 9, respectively,
and thus contribute to virulence [46–52]. However, as the substrate
of ZmpD is unknown, it is not clear whether this enzyme plays a role
in virulence. Other strains harboring zmpD include ATCC 700669,
JJA, G54, CGSP14 and INV200, and the gene was detected in 49%
of 218 mostly invasive disease isolates in one study [53]. The large
conjugative transposon Tn5253 is a composite element consisting of
regions from Tn916 and Tn5252 and contains genes that confer
resistance to tetracycline and chloramphenicol [54,55]. In the
highly virulent serotype 1 isolates, the region encodes a putative TA
system homologous to PezAT in PPI-1 and an umuCD-like operon.
UmuCD is involved in a branch of the SOS response in E. coli and
in S. pneumoniae has been shown to confer greater UV tolerance
[56,57]. Whilst a number of other strains contain distinct Tn5252
and Tn916 elements with homology to region 5, ATCC 700669
also harbors the compositeTn5253 element [43].
Region 6 encodes a putative high-affinity iron/lead permease
and a fragmented DyP-type peroxidase that are homologous to
SPP_1340 and 1341, respectively in P1031. This region is inserted
between homologues of SPINV104_11210 and 11240 in INV104
and SP_1299 and 1306 in TIGR4. In both TIGR4 and INV104
the corresponding region consists of a number of small
hypothetical genes. Whilst the substrate of the permease in region
Table 2. Genomic regions present only in the genomes of the highly virulent isolates.
Region (AR)* Size
Putative annotation/function of key
gene(s) in region Homologous ORFs Other genomes
#
P1031 TIGR4 D39 A B C D E F G
1 35 kb Group 1 pneumophage (pblB-like, endolysin) 0028–0083 - - 2 ‘ ‘ 2 ‘ 2 2
2 1 kb Sodium-dependent permease, transcription
regulator (MerR)
0750–0751 0739–0740 0643–0644 + + + + 2 + +
3 (22) 6.3 kb PPI-1v (PezAT, NplT) 1049–1058 1046–1056 0927–0936 + + + 2 2 2 +
4 (22) 8 kb PPI-1v (Metabolic/hypothetical) 1059–1069 - - 2 2 2 2 2 + 2
5 58 kb ZmpD, Tn5253 (TA system, UmuCD) 1141–1198 - - + 2 2 2 2 ‘ ‘
6 1.7 kb High-affinity iron/lead permease 1340–1343 - 1155–1157 2 2 2 2 ‘ 2 +
7 2.9 kb ABC-type transporter, transcription regulator (ArsR) 1637–1643 - - 2 2 2 2 2 2 2
8 (28) 18 kb ABC transporter, sialic acid degradation enzymes 1350–1371 1346–1349‘ 1164–1183 ‘ ‘ ‘ 2 ‘ ‘ ‘
*AR designated by Bloomberg et al. [14].
#Presence in other S. pneumoniae genomes; A, ATCC 700669; B, JJA; C, 70585; D, Taiwan19F-14 ; E, Hungary19A-6; F, G54; G, CGSP14.
+, Region present; ‘, Region partially present; 2, Region absent; Confirmed by BLAST searches of the KEGG database.
A detailed list of genes present in each AR is included in Table S2.
doi:10.1371/journal.pone.0019650.t002
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6 requires experimental confirmation, other pneumococcal
transporters of metal ions such as Psa (manganese) and Pia (iron)
are important in pneumococcal pathogenesis [58–63]. The
putative metal permease is also present in the genomes of D39,
Hungary19A-6, CGSP14, INV200 and CDC3059-06.
Region 7 encodes a putative ArsR family transcriptional
regulator, and an ABC-2 type transporter including the trans-
membrane and ATP-binding components homologous to
SPP_1779 and 1780 in P1031, respectively. The region is absent
in both TIGR4 and INV104, and if present would be inserted
between SP_1779 and 1780, and SPINV104_15230 and 15250,
respectively. ArsR family transcriptional regulators are often
responsive to metal ions, and like MerR regulators, have been
implicated in resistance against environmental stresses [64].
Examination of other pneumococcal genome sequences revealed
that strains MLV-016, 11-BS70, 9-BS68, 14-BS69 and 18-BS74
also harbor this region.
Region 8 is homologous to SPP_1350–1367 in P1301, which
corresponds to the previously described AR 28 [14]. In particular,
the AR 28 subregion RD8b1 [10,65] encodes a putative ABC
transporter for the transport of glutathione and putative N-
acetylmannosamine-6-phosphate 2-epimerase, kelch-like protein,
glycoside hydrolase family protein and N-acetylneuraminate lyase
genes. Much of this region is also present in D39 (SPD_1164–
1174). A putative ABC transporter is also encoded within the
same, but divergent region in the non-invasive and intermediately
virulent isolates (Table 3). The transporter appears to be similar to
the LplABC polysacchaide transporter in Bacillus subtilis and
Agrobacterium radiobacter [66]. Glycoside hydrolase and N-acetyl-
mannosamine-6-phosphate epimerase genes present within the
region in both groups of strains share 50% nucleotide sequence
identity. Putative diadenosine tetraphosphate hydrolase and
dihydrolipoamide dehydrogenase genes also exist in this region
in the intermediately virulent and non-invasive isolates. Further-
more, the AR 28 subregion RD8b2 that is homologous to
SP_1345–1349 in TIGR4 and includes a second ABC transporter
[10,65] is present in the non-invasive and intermediately virulent
isolates, but absent in the highly virulent isolates. The RD8b3
Figure 3. Alignment of PPI1v between ATCC 700669, 1, 1861 and G54. The nucleotide sequences of PPI-1v were aligned using the artemis
comparison tool between ATCC 700669, 1, 1861 and G54. Strain 1 represents the non-invasive and intermediately virulent isolates, and strain 1861
represents the highly virulent isolates. Blue shading between strains indicates nucleotide sequence identity exceeding 90%. Green arrows indicate
the nplT ORFs, red arrows indicate the pezAT operon, orange arrows indicate ORFs within divergent sequence that are absent in strain 1, yellow
arrows indicate ORFs that are absent in strain 1861 and purple indicates ftsW. Tn5252 ORFs are not shown.
doi:10.1371/journal.pone.0019650.g003
Figure 4. General component structure of PPI-1v. Summary of PPI-1v derived from alignments of the region between ATCC 700669, 1, 1861
and G54. Blue indicates regions of shared sequence between the aligned strains, red indicates the pezAT region and yellow indicates a region of
divergent sequence (accessory region).
doi:10.1371/journal.pone.0019650.g004
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subregion that is homologous to SP_1345–1349 and was reported
to be required for wild-type virulence in TIGR4 [65], was present
in all six serotype 1 isolates in this study. The overall region in the
non-invasive and intermediately virulent isolates is homologous to
INV104_11270–11410 in INV104.
Key regions found not be associated with a virulence
phenotype in this study
Previous genomic comparisons have identified a number of ARs
that were associated with clonal clusters with high invasive
potential. While it is likely that a number of these regions are
involved in virulence, it is unlikely that they are responsible for the
differences in virulence that we observed between the strains in
this study. ARs 5, 6, 9, 15, 20, 21, 29 and 39 were reported to be
present in the majority of tested isolates from highly invasive clonal
clusters [14]. In particular, ARs 5, 6, 15 and 29 have previously
been shown to impact virulence using signature tagged mutagen-
esis (STM) [67,68]. However, AR 5 is absent in all six isolates in
this study (Table 4), and AR 6 is present only in the lineage A
isolates and not in the highly virulent isolates. ARs 9, 15, 20, 21,
29 and 39 were present in all six strains, which is not surprising
since Blomberg et al. [14] found that these regions are present in
the majority of serotype 1 isolates that were tested in their study
[14]. However, this finding implies that these regions are not
responsible for the virulence differences between the isolates in this
study. In addition, AR 6 is also not likely to be required for the
heightened virulence of strains 1861 and 4496. Furthermore, ARs
10, 16, 19 and 27 were shown to be present in some serotype 1
isolates, and not others [14]. In this study ARs 16 and 19 were
present in all isolates and AR 10 was present in the lineage A
isolates, but not the highly virulent isolates (Table 4). Similar to
Blomberg et al., [14] the presence of AR 27 did not appear to
correlate with the invasive potential of the strains in this study
(Table 4) [10,14]. Whilst the deletion of AR 31 has previously
been reported to significantly reduce the virulence of TIGR4 [65],
the region was present in strain 1861, but not in either strain 4496
or the lineage A strains. Therefore, the region is unlikely to be
responsible for the differences in virulence between serotype 1
isolates in this study. In addition, ARs 11, 30 and 34, which
encode the pilus, pneumococcal collagen-like protein (PclA) and
PsrP, respectively, have been implicated in virulence
[10,16,19,69]. However, AR 11 was absent in all six isolates,
and AR 34 was present in the intermediately virulent isolates and
strain 1861, but not in the non-invasive isolates or strain 4496. AR
30 was present only in the intermediately virulent isolates.
Therefore, these regions are unlikely to be important for the
differences in virulence between the isolates in this study. In
addition to the pilus encoded within the rlrA islet, there is a second
pilus (PI-2), which has been reported to be present in emerging
serotypes such as 1, 2, 7F and 19A and is homologous to
SPT_1056–1064 in Taiwan19F-14 [70]. However, genome se-
quencing and PCR (data not shown) showed that PI-2 is present in
the non-invasive and intermediately virulent isolates, but absent in
the highly virulent isolates. Therefore, possession of PI-2 is not
required for the heightened virulence of strains 1861 and 4496.
Differential in vivo expression of key virulence-associated
genes
Genes associated with heightened virulence (Tables 2 and 3) were
selected for in vivo gene expression comparisons to identify genes that
exhibit niche-specific changes in expression. Expression analysis was
performed on nasal lavage, blood and lung samples of strain 1861-
and 4496-infected mice (Figure 2), using qRT-PCR. Expression of
the endolysin, nplT, 3HIBDH and iron/lead permease was elevated
in the blood and lungs of both strain 1861- and 4496-infected mice,
when compared to the nasopharyngeal lavage fluid (Table 5), which
suggests that the products of these genes are more important in the
blood and lungs than the nasopharyngeal surface. Interestingly,
since endolysin activity has been shown to be required for PblB
surface expression in S. mitis [33], surface expression of this potential
adherence factor could be indirectly elevated in the lungs and blood
due to endolysin activity, despite little difference in pblB expression
between niches. In PPI-1v, 3HIBDH is part of an operon that also
encodes PDT and galE (data not shown), which implies that the
expression of all three of these enzymes is elevated in the lungs and
blood compared to the nasopharyngeal surface. While the activities
of these genes remain to be confirmed experimentally, the products
of these genes could provide a survival advantage and facilitate
disease. Interestingly, expression of the iron/lead permease was
greatest in the blood followed by the lungs and lowest on the
nasopharyngeal surface, which suggests that this transporter is more
important in the blood and lungs than on the nasopharyngeal
mucosa. Expression of the major facilitator transporter in PPI-1v
and the glycoside hydrolase in region 8 was significantly greater in
the blood than either the lungs or nasopharyngeal surface.
However, since the substrate of the major facilitator is unknown it
is not clear whether the expression of this gene provides a survival
advantage in this niche. As the glycoside hydrolase is encoded
immediately downstream of the putative ABC transporter in region
8, and no expression-attenuating secondary structures were
predicted in the intervening sequence, it is likely that the expression
of this enzyme reflects the expression of the ABC transporter.
Expression of the sodium-dependent permease, pezAT and biotin
carboxylase expression in PPI-1v did not appear to be niche-specific
since changes in the expression of these genes were not consistent
between the two strains.
Table 3. Genomic regions of the non-invasive and intermediately virulent isolates that replaced regions associated with the highly
virulent strains.
Region (AR) Size
Putative annotation/function
of key gene(s) in region Homologous ORFs Other genomes
#
INV104 TIGR4 D39 A B C D E F G
4 (22) 5.5 kb PPI-1v (Mersacidin immunity ABC
transporter)
09130–09190 - - + 2 2 2 2 2 2
8 (28) 24 kb Polysaccharide ABC transporter
(LplBC-like),
11270–11410 - - 2 2 2 2 + 2 2
#Presence in other S. pneumoniae genomes; A, ATCC 700669; B, JJA; C, 70585; D, Taiwan19F-14 ; E, Hungary19A-6; F, G54; G, CGSP14.
+, Region present; ‘, Region partially present; 2, Region absent; Confirmed by BLAST searches of the KEGG database.
doi:10.1371/journal.pone.0019650.t003
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Table 4. Other notable regions not consistently associated with a virulence profile in this study.
AR*
Putative annotation/function of key
gene(s) in region Homologous ORFs Serotype 1 isolates
TIGR4 D39 1 2 3415 5482 1861 4496
5 Hypothetical proteins 0296–0298 - 2 2 2 2 2 2
6 b glucosidase, PTS – metabolic 0300–0310 0276–0283 + + + + 2 2
9 Mevalonate pathway - metabolism 0382–0387 0347–0390 + + + + + +
10 Mannitol PTS 0394–0399 0360–0364 + + + + 2 2
11 RlrA islet - adherence 0461–0468 - 2 2 2 2 2 2
15 b-galactosidase – metabolism 0643–0648 0559–0562 + + + + + +
16 Zinc metalloproteinase B 0664–0666 - + + + + + +
19 Type I restriction modification system 0887–0890 - + + + + + +
20 Amino acid metabolism 0918–0923 0811–0816 + + + + + +
21 CelA - competence 0949–0954 0839–0843 + + + + + +
27 V-type sodium ATP synthase 1315–1331 - 2 2 + + 2 2
29 ABC transporter 1432–1442 1261–1272 + + + + + +
30 Collagen-like protein, PclA – adherence - 1376–1377 + + + + 2 2
31 Ribulose PTS - uptake of ribulose 1612–1620 - 2 2 2 2 + 2
34 PsrP-secAY2A2 - adherence 1755–1772 - 2 2 + + 2 +
39 Type II restriction modification system 1930–1936 1731–1736 + + + + + +
- PI-2 adherence - - + + + + 2 2
*AR designated by Bloomberg et al. [14].
+, Region present; 2, Region absent; Determined from genome sequence of strains 1 and 1861, and by CGH for strains 2, 3415, 5482 and 4496. Presence of PI-2 was
determined by PCR.
doi:10.1371/journal.pone.0019650.t004
Table 5. Relative expression of selected virulence associated genes between different niches of the mouse.
Gene Region+ Expression
‘
Blood vs. nose Lungs vs. nose Blood vs. lungs
1861 4496 1861 4496 1861 4496
pblB 1 +1.22ns +1.79ns +1.17ns 22.43b +1.04ns +1.36ns
Endolysin 1 +1311.20*c +221.32*c +1028.74*c +220.30*c +1.27ns 1.00ns
Na+ dep. transporter 2 21.28ns 21.28ns 23.15c +1.54 +2.47b 21.97ns
nplT 3 +55.72c +42.62c +28.38*c +69.07*c +1.96ns 21.62ns
pezAT 3 +1.06ns +11.71c 21.70ns +1.14ns +1.80ns +10.29c
3HIBDH 4 +64.59*c +432.53*c +115.89*c +97.46*c 21.79ns +4.44c
Biotin carboxylase 4 21.63ns +97.01c 22.61c +9.78c +1.60ns +9.92c
Major facilitator 4 +3.27c +10.95c +1.08ns +2.04c +3.03c +5.36c
Fe2+/Pb2+permease 6 +5.92c +24.36c +2.17c +12.10c +2.73a +2.01a
Gly. Hydrolase 8 +29.18*c 369.65*c -# -# +624.55*c +25.22c
*Indicates where the target mRNA was below the limit of detection in nasal wash-derived RNA.
#Indicates where the target mRNA was below the limit of detection in both samples.
‘The values represent the relative amounts of mRNA in the first niche compared to the second.
Results of statistical analysis using t-test: ns, not significant (includes values ,2);
a, P,0.05;
b, P,0.01;
c, P,0.001.
+As numbered in Table 2.
doi:10.1371/journal.pone.0019650.t005
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In vivo competition between D39 PPI-1 mutants
replacing the endogenous version of the region with the
regions of strain 1 and strain 1861
Since the content of PPI-1v varies between the highly virulent
isolates and the four less virulent isolates, and the expression of a
number of PPI-1v genes was favored in niches associated with
disease, it was decided to confirm the role of this region in
virulence determination by mutagenesis. However, a significant
roadblock to such experiments was the inability to genetically
transform the serotype 1 isolates in this study, despite numerous
attempts using various known transformation protocols. There-
fore, it was decided to construct PPI-1v derivatives in the easily
transformable laboratory strain D39 [71], which has a different
version of PPI-1v compared to strain 1 and 1861. Derivatives of
PPI-1v were constructed and used to replace the endogenous
region with the version of the region in the highly virulent isolates
(designated D391861) and the version in the non-invasive isolates
(designated D391). PPI-1v in D391 was also representative of that
present in the intermediately virulent isolates. In addition, a PPI-
1v deletion mutant (D39DPPI-1) was constructed to examine the
contribution of the wild-type D39 version of PPI-1v to virulence.
In order to obtain a D39DPPI-1 knockout, an intermediate mutant
lacking pezT (D39DPezT) was constructed by replacing
SPD_0931–0951 with ermR, as simultaneous deletion of pezA and
pezT has been reported to be lethal [44]. The subsequent
D39DPPI-1 mutant was constructed from D39DPezT by replacing
SPD_0927–0930 with cmlR. D391 was also constructed from
D39DPezT by replacing the remaining non-homologous D39
PPI-1v sequence (SPD_0927–0930) with strain 1 sequence
(SPINV104_09310–09190) (Fig. 5A). D391861 was constructed by
replacing the non-homologous D39 PPI-1v sequence (SPD_0936–
0951) with strain 1861 PPI-1v sequence (SPP_1056–1072) (Fig. 5B).
Expression of 1861-derived PPI-1v genes in D391861 was
confirmed in vitro by qRT-PCR (data not shown). In addition,
there was no detectable difference in in vitro growth rate between
the mutants and D39 (data not shown). The ability of the mutants
and wild-type to cause disease was subsequently compared in mice
using mixed infections using the combinations D39 vs. D39DPPI-
1, D39 vs. D391, D39 vs. D391861 and D391861 vs. D391. Data
were obtained from the nasal lavage fluid, nasal tissue, lungs and
blood at both 24 h and 48 h post-challenge. At 24 h both
D39DPPI-1 and D391 were less competitive than the wild type in
both the lungs and blood (Fig. 6A and 6B). However, D391 was
more competitive than the wild-type at the nasopharyngeal
surface. In contrast, there was no significant difference between
D391861 and the wild type in the blood, lungs or nasal tissue
(Fig. 6C). However, D391861 was more competitive than the wild
type on the nasopharyngeal mucosa. Interestingly, D391861 was
more competitive than D391 in all four niches (Fig. 6D).
Furthermore, at 48 h the wild type was more competitive than
D39DPPI-1 in the nasal tissue, lungs and blood (Fig. 6E). In
contrast, D391 was less competitive than the wild type in the nasal
tissue and the lungs, but was equally competitive in the blood at
48 h (Fig. 6F). Similar to 24 h, D391816 was as competitive as the
wild-type in the nasal tissue, blood and lungs, but more
competitive on the nasopharyngeal surface at 48 h (Fig. 6G).
D391861 was also more competitive than D391 in the nasal tissue
and blood, but equally competitive in the lungs and at the
nasopharyngeal surface (Fig. 6H). In summary, it is clear that PPI-
1v plays a role in virulence in a D39 background, and that it is
possible that PezAT is important as has been previously reported
[42]. However, the importance of other components of PPI-1v in
virulence cannot be ruled out. In addition, while the endogenous
version of PPI-1v is required for wild-type virulence in D39, it is
also true that in a D39 background, PPI-1v from the highly
virulent serotype 1 strains was also more competitive than PPI-1v
from the non-invasive and intermediately virulent serotype 1
isolates in a number of niches, which correlates with differences in
virulence between the isolates in both mice and humans.
Therefore, while it is possible that the relative impact of PPI-1v
on virulence could be different in a D39 background than in the
serotype 1 isolates themselves, the correlation between the
virulence of the wild-type strains, the niche-specific changes in
expression of PPI-1v genes and in vivo competition between PPI-1v
D39 mutants is compelling.
This study aimed to identify serotype-independent virulence
determinants within the genomes of a selection of serotype 1
isolates with wide-ranging virulence in both mice and humans. In
particular, isolates closely related to the hypervirulent clones
responsible for epidemic IPD were found to readily invade and
survive in the blood, whereas non-invasive clones isolated from
episodes of asymptomatic serotype 1 carriage in remote Indige-
nous Australian communities were only able to colonize the
nasopharynx in mice. A number of regions .1 kb in size were
present in the genomes of only the highly virulent isolates, which
included a phage genome with putative adherence factors, a
number of putative metabolic enzymes, an ABC transporter, an
ion transporter as well as a number of potential stress-responsive
transcriptional regulators. In particular, the expression of some
metabolic enzymes, transporters and adherence factors appeared
to exhibit preferential expression in niches associated with IPD. In
addition, the various versions of PPI-1v were shown to impact on
virulence differently and suggests that this region is at least partly
responsible for the greater virulence of highly virulent isolates
compared to less virulent isolates. PPI-1v appears to be a highly
variable AR within the pneumococcal genome that alters the
survival of the bacterium within the host in a content-dependent
fashion.
Materials and Methods
Ethics statements
This study was conducted in compliance with the Australian
code of practice for the care and use of animals for scientific
purposes (7th Edition 2004) and the South Australian Animal
Welfare Act 1985. All animal experiments were approved by the
Animal Ethics Committee of the University of Adelaide (Project
Number: S- 86-2006). Written consent was obtained for studies of
human specimens and ethics approval was obtained for further
molecular analyses from the Human Research Ethics Committe of
the Menzies School of Health Research and Department of
Health and Families.
Strains and media
The S. pneumoniae serotype 1 clinical strains used in this study
that were of Indigenous Australian origin included non-invasive
isolates (strains Menzies1-1 [ST304] and Menzies1-2 [ST304]),
and invasive isolates (strains Menzies1-3415 [ST227], Menzies1-
5482 [ST227] and Menzies1-1861) and were provided by the
Royal Darwin Hospital Pathology Services. An invasive serotype 1
isolate (strain WCH4496) was of non-Indigenous origin and was
obtained from the Women’s and Children’s Hospital, North
Adelaide, Australia. The virulent serotype 2 strain, D39 (NCTC
7466) was also used in this study. The sequence type (ST) of
serotype 1 strains was determined by MLST as described in
Enright & Spratt (1998) and in accordance with the instructions at
http://spneumoniae.mlst.net. Opaque-phase variants of all strains
selected on Todd-Hewitt broth supplemented with 1% yeast
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extract (THY)-catalase plates [72] were used in all animal
experiments. Before infection, the bacteria were grown in serum
broth (SB) (nutrient broth [10 g/l peptone (Oxoid), 10 g/l Lab
Lemco powder (Oxoid) and 5 g/l NaCl] and 10% [v/v] donor
horse serum) to an optical density at 600 nm (OD600) of 0.16,
which approximates 16108 CFU/ml.
PCR
Chromosomal DNA for PCR was extracted and purified using the
Wizard genomic DNA purification kit (Promega Corporation,
Madison, WI), with the exception of cell lysis, which was performed
by incubating cells at 37uC for 10 min with 0.1% (w/v) sodium
deoxycholate. PCR reactions were performed using a G-STORM
GS482 thermal cycler (Gene Technologies, UK). Standard reactions
were performed using Taq DNA polymerase (Roche Diagnostics,
Basel Switzerland) according to the manufacturer’s instructions. The
ExpandTM Long template or High fidelity PCR systems were used
when high fidelity amplification was required. Overlap-extension
PCRwas carried out essentially as previously described [73,74], using
the ExpandTM Long Template PCR system. DNA sequencing
reactions were carried out using the BigDyeH Terminator v3.1 Cycle
Sequencing kit (Applied Biosystems, CA, USA).
Animal studies
Inbred 5- to 6-week old female Balb/c mice were used in i.p.
challenge experiments and outbred 5- to 6-week old female CD1
(Swiss) mice were used in i.n. challenge experiments. For i.p.
challenge experiments groups of 5 mice were used. Mice were
challenged i.p with 100 ml of bacterial suspension containing
approximately 16104 CFU in SB. The challenge dose was
confirmed retrospectively by serial dilution and plating on blood
agar. Mice were monitored for signs of illness over 9 days and were
euthanized when moribund. Blood was taken from euthanized
mice and plated on blood agar to confirm the presence of S.
pneumoniae in the blood. For i.n. challenge, groups of 10 mice were
anaesthetized by i.p. injection of pentobarbital sodium (Nembutal;
Rhone-Merieux) at a dose of 66 mg per g of body weight and
challenged with 50 ml of bacterial suspension containing approx-
imately 16107 CFU in SB. The challenge dose was confirmed
retrospectively as described above for i.p. challenge. For
quantification of pneumococci and gene expression analysis in
infected mouse tissues, groups of 30 mice for strains Menzies1-
1861 and WCH4496 and a group of 20 mice for strain Menzies1-1
were challenged via the i.n. route with anesthesia as described
above. At 48 h and 96 h, the mice were euthanized by CO2
Figure 5. Construction of PPI-1v derivatives in D39 representing strains 1 and 1861. The PPI-1v derivatives D391 (A) and D391861 (B) were
constructed to reflect the organization of the region in the lineage A strains and highly virulent isolates, respectively. PPI-1v alignments between the
D39 wild-type region and the region in strains 1 (A) and 1861 (B) indicate nucleotide sequence identity exceeding 90%, and highlights the non-
homologous wild-type sequence that was replaced. The approximate sites of homologous recombination were subsequently determined by
sequencing and are indicated by broken lines. The PPI-1v accessory region of strains 1 and 1861 are colored yellow and the wild-type PPI-1v
accessory region is colored orange. The relative position of the antibiotic resistance genes conferring resistance against chloramphenicol (cmlR) and
spectinomycin (speR) are indicated in the final mutant.
doi:10.1371/journal.pone.0019650.g005
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asphyxiation, and nasal lavage, nasal tissue, lung and blood
samples were processed as previously described [75,76]. A 40-ml
aliquot of each sample was serially diluted in phosphate-buffered
saline and plated on blood agar to enumerate pneumococci
present in each niche and to determine the presence, if any, of
contaminating microflora. Blood plates were incubated at 37uC in
95% air, 5% CO2 overnight. Samples were then stored at 280uC
until further processing was performed. In addition, a 400-ml
aliquot of blood and homogenized nasal and lung tissue was also
harvested from each mouse for extraction of prokaryotic RNA.
For in vivo competition experiments, two replicate experiments
with groups of ten mice per competition group were challenged
i.n. (as described above) with a mixed culture of approximately
56106 CFU per strain. The competitive index (CI) within nasal
wash, nasal tissue, blood and lung samples was determined at 24 h
and 48 h post-challenge on selective media by calculating the ratio
of wild-type to mutant or mutant to mutant as required, relative to
the input ratio. As the CI values were log transformed, a value
close to 0 is expected if strains compete equally.
Extraction of total RNA from infected host tissues
RNA was extracted from host tissues, purified and enriched for
bacterial RNA essentially as described previously [75,77]. In this
experiment bacterial RNA was pooled from the same 4 mice per
niche.
Linear amplification of total RNA
Bacterial-RNA samples were amplified using a RNA linear
amplification kit SenseAMP (Genisphere), as described previously
[75,77].
Real-time relative qRT-PCR
The abundance of mRNAs of the genes listed in Table 5 present in
amplified RNA recovered from pneumococci harvested from all
niches was measured by real-time quantitative RT-PCR (qRT-PCR).
Gene specific primers were designed using OligoPerfectTM software
(Invitrogen), and primers specific for 16S rRNA were used as internal
controls for data normalization (Table S1). qRT-PCRwas performed
using a LightCyclerH 480 II (Roche) using the Superscript III One-
step RT-PCR kit (Invitrogen) according to the manufacturer’s
instructions. Quantitative differences for each transcript were
calculated using the 22DDCT method [78]. Expression data are
expressed as a relative increase/decrease between niches.
Comparative Genomic Hybridization
Comparative genomic hybridization (CGH) experiments were
performed on whole genome S. pneumonia PCR microarrays based
on TIGR4 and R6 annotations. Microarray slides were obtained
from the Bacterial Microarray Group at St George’s Hospital,
University of London. The microarray design is available in
BmG@Sbase (Accession No. A-BUGS-14; http://bugs.sgul.ac.
uk/A-BUGS-14) and ArrayExpress (Accession No. A-BUGS-14).
S. pneumoniae DNA for CGH was extracted and purified using a
phenol extraction method as described previously [79]. DNA
(10.5 mg in 100 ml) was digested with Sau3AI (New England
Biolabs [NEB], MA, USA), and purified using the Qiagen
MinEluteH PCR Purification kit. Thereafter, 20 ml of purified
digest was labeled using the Genisphere Array 900 DNATM DNA
labeling kit for Microarrays (Genisphere, PA, USA) for each of
the dyes used (Alexa Fluor 555 and Alex Fluor 647). Slides were
incubated overnight in a dark humidified chamber at 65uC,
washed in a 3-step process (15 min with 26 SSC, 0.03% (v/v)
SDS, at 65uC; 15 min with 16SSC, RT; 15 min with 0.26SSC,
at RT) and dried. Slides were scanned using GenePixH Pro 6.0
software (Axon). CGH was performed in pairs of strains with the
same virulence phenotype per slide (1 & 2, 3415 & 5482, 1861 &
4496). Approximately equal fluorescence per spot on the array
between channels on one slide indicated presence in both strains
of the same phenotype, unequal fluorescence indicated presence
only in one strain of the same virulence phenotype, and
fluorescence not significantly different from the background
indicated absence in both strains of the same virulence
phenotype.
Genomic sequencing
Sequencing and genome assembly were performed by Gene-
works (Thebarton, Adelaide, Australia) using chromosomal DNA
prepared as described for CGH, using an Illumina Genome
Analyzer II (California, USA) and LasergeneH 8 software
(DNASTAR Inc, WI, USA). The sequenced 35-bp reads were
assembled against the P1301 (serotype 1, ST303) genome
(Genbank accession no. CP000920). The assembly of the strain 1
reads generated a 1,947,650-bp consensus sequence (92.22% of
P1031) with an average read depth of 35.72 reads. The assembly of
the strain 1861 reads generated a 2,105,218-bp consensus
sequence (99.68% of P1031) with an average read depth of
43.66 reads. Unassembled sequences were subsequently assembled
de novo into 103 and 62 contigs .300-bp in size from strain 1 and
1861, respectively. While many smaller contigs of boneyard
sequence were assembled, these largely represented gaps in
sequence assembly due to sequence variation below the 80%
sequence identity cutoff. The genome sequence of INV104
(Genbank accession no. FQ312030), ATCC 700669 (Genbank
accession no. FM211187), G54 (Genbank accession
no. CP001015) and D39 (Accession no. NC_008533) were used
in comparisons. Alignments were performed using the Artemis
Comparison Tool (ACT) [80]. The sequences of strains 1 and
1861 were submitted to the sequence read archive at NCBI and
have accession numbers SPX030816.2 and SPX030825.2, respec-
tively.
Construction of PPI-1 variable region mutants
Mutants were constructed using the primers in Table S1.
Mutants requiring the deletion of pezAT were performed in two
steps. D39DPPI-1 and D391 were constructed from D39DPezT.
The construct for D39DPezT was generated by overlap extension
PCR, performed essentially as described below, from products
amplified using primers a – aq and ec – g for the flanking products
and J214–J215 for the amplification of ermR from pVA891 [81].
The construct for D39DPPI-1 was generated by restriction
endonuclease treatment and subsequent ligation using primers t
– ed and ee – g for the flanking products amplified from D39 and
Figure 6. Competition between PPI-1v derivatives and wild type in the nasopharynx, blood and lungs. Competitive index (CI) within
nasal lavage, nasal tissue, blood and lung samples of individual mice are indicated at 24 h (A–D) and 48 h (E–H) post-challenge. CIs are expressed as
log-transformed ratios of the first strain relative to the second strain for mice where pneumococci CFU were recovered from the relevant niche.
Values are pooled from two replicate experiments that used 5 mice per group at each time point. Statistical differences between the log-transformed
geometric mean CI and a hypothetical value of 0 (ratio of 1:1) in each niche were analyzed using the one-sample t-test (*, P,0.05; **, P,0.01;
***, P,0.001).
doi:10.1371/journal.pone.0019650.g006
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RHcatF – RHcatR for amplification of cmlR. The construct for
D391 was generated by restriction endonuclease treatment and
subsequent ligation using primers af – ei and ej – g for the flanking
products amplified from strain 1 DNA and cmlR. The construct for
D391861 was generated by restriction endonuclease treatment and
subsequent ligation using primers ef – eg and eh – c for the flanking
products amplified from strain 1861 DNA and J293a–J254a for
amplification of speR. Generation of competent S. pneumoniae cells
and subsequent transformation was performed using the complete
transformation medium (CTM) method [82,83].
Statistical analyses
Differences in median survival times and differences in the
geometric mean number of pneumococci in each niche between
groups were analyzed by the unpaired t-test (two tailed).
Differences in the relative expression levels of genes between
niches were performed using the unpaired t-test (two tailed).
Differences between the competitive index of a test sample and
CI= 1 were analyzed using log-transformed values by one-sample
t-test. All analyses were performed using GraphPad Prism version
5.01. P,0.05 was considered significant.
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